Pancreatic Cancer Research

ResearcherThe University of Texas Health Science Center at HoustonNo recent work listed

Xiaodong Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3479-1694; OpenAlex author ID A5080619609. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper

Papers 4

  1. Lithium and an EPAC-specific inhibitor ESI-09 synergistically suppress pancreatic cancer cell proliferation and survival. Co-author DOI 10.1093/abbs/gmx045↗
  2. Phycocyanin Inhibits Tumorigenic Potential of Pancreatic Cancer Cells: Role of Apoptosis and Autophagy. Co-author DOI 10.1038/srep34564↗
  3. Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo. Last author DOI 10.1124/mol.114.095158↗
  4. A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion. Last author DOI 10.1124/mol.112.080689↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xinshuo Wang · 1 shared paper, 2017 · strength 0.10
  2. Meiling Lü · 1 shared paper, 2017 · strength 0.10
  3. Muayad F. Almahariq · 2 shared papers, 2013–2015 · strength 0.09
  4. Gaoyong Liao · 1 shared paper, 2016 · strength 0.07
  5. Yu Ou · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.